Colby Evans, MD

home / authors / colby-evans-md

Articles

November 1st 2022

Overview of Biosimilars for Immune-Mediated Inflammatory Diseases: Summary of Current Evidence

Vibeke Strand, MD Colby Evans, MD Allan Gibofsky, MD, JD

November 1st 2022

Biosimilar medicines: what are they and how are they used?

Vibeke Strand, MD Colby Evans, MD Allan Gibofsky, MD, JD

Plain Language Summary

November 1st 2022

Provider and Patient Knowledge Gaps on Biosimilars: Insights From Surveys

Allan Gibofsky, MD, JD Colby Evans, MD Vibeke Strand, MD

November 1st 2022

What do patients and health care providers still need to know about biosimilar medicines?

Allan Gibofsky, MD, JD Colby Evans, MD Vibeke Strand, MD

Plain Language Summary

November 1st 2022

eAppendix: Provider and Patient Knowledge Gaps on Biosimilars: Insights From Surveys

Allan Gibofsky, MD, JD Colby Evans, MD Vibeke Strand, MD

November 1st 2022

Biosimilars for Immune-Mediated Inflammatory Diseases – A Managed Care Perspective

Colby Evans, MD Allan Gibofsky, MD, JD Vibeke Strand, MD

November 1st 2022

What are the current challenges to wider biosimilar use in the United States?

Colby Evans, MD Allan Gibofsky, MD, JD Vibeke Strand, MD

Plain Language Summary

June 20th 2016

Managed Care Aspects of Psoriasis and Psoriatic Arthritis

Colby Evans, MD

Latest Updated Articles

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Glaucoma | Image credit: Yakobchuk Olena - stock.adobe.com

Published: November 12th 2024 | Updated: November 14th 2024

Polygenic Risk Score Important to Track POAG Onset

1 KOL is featured in this series.

Published: November 8th 2024 | Updated: November 14th 2024

Looking Ahead: Anticipating Changes in Lupus Guidelines and Clinical Practice

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions